Clinical Trials Directory

Trials / Completed

CompletedNCT02428699

Study Comparing Blood Levels of Fatty Acids After Consuming Two Forms of Cod Liver Oil

Comparison of Plasma Levels of n-3 Fatty Acids After Ingestion of an Emulsified Cod Liver Oil Product and a Non Emulsified Cod Liver Oil Product

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is designed to compare the incremental area under the curve from 0 to 24h (iAUC0-24h) of plasma levels of n-3 fatty acids (sum of total and free eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) after ingestion of an emulsified product and a non-emulsified reference control of free flowing cod liver oil at the lowest appropriate dose that is practically acceptable, and as near as possible to the test products' recommended daily dose.

Detailed description

Many dietary lipids are in the form of triglycerides, ethyl esters or phospholipids. During digestion these lipids are subject to hydrolysis, in particular by pancreatic triglyceride lipase. To facilitate the action of the enzyme, lipids are emulsified by the action of bile salts. By increasing the surface area of the fat globules, emulsification increases access to the lipids by pancreatic triglyceride lipase. This study is designed to compare iAUC0-24h of plasma levels of n-3 fatty acids (sum of total and free EPA and DHA) after ingestion of an emulsified product and a non-emulsified reference control of free flowing cod liver oil at the lowest appropriate dose that is practically acceptable, and as near as possible to the test products' recommended daily dose.

Conditions

Interventions

TypeNameDescription
OTHEREmulsified cod liver oil productParticipants are required to consume the dose (30 mL) within 1 min, followed by up to 300 mL of apple juice which needs to be consumed within 2 min
OTHERNon-emulsified cod liver oil productParticipants are required to consume the dose (5.8 mL) within 1 min, followed by up to 300 mL of apple juice which needs to be consumed within 2 min

Timeline

Start date
2015-05-20
Primary completion
2015-07-15
Completion
2015-07-15
First posted
2015-04-29
Last updated
2018-08-28
Results posted
2018-08-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02428699. Inclusion in this directory is not an endorsement.